Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Historical Holders from Q2 2021 to Q3 2025

Symbol
DAWN on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
101,996,650
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
85,449,652
Holdings value
$602,397,710
% of all portfolios
0.002%
Number of holders
169
Number of buys
83
Number of sells
-95
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 9.9% -11.8% $71,188,562 -$8,777,469 10,097,668 -11% FMR LLC 30 Sep 2025
BlackRock, Inc. 5.8% +22% $38,061,315 +$6,751,002 5,849,917 +21.6% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 85,449,652 $602,397,710 -$3,593,242 $7.05 169
2025 Q2 86,186,499 $560,206,343 -$67,566,968 $6.5 173
2025 Q1 94,058,917 $745,890,533 -$40,487,714 $7.93 183
2024 Q4 93,739,417 $1,187,690,667 -$5,879,821 $12.67 163
2024 Q3 92,050,053 $1,283,687,781 +$239,491,695 $13.93 165
2024 Q2 74,705,046 $1,029,464,955 +$17,373,333 $13.78 155
2024 Q1 72,782,347 $1,202,300,406 -$58,498,635 $16.52 147
2023 Q4 76,570,666 $1,117,957,204 -$50,224,829 $14.6 138
2023 Q3 77,547,732 $951,517,363 -$22,223,998 $12.27 127
2023 Q2 78,803,713 $941,011,552 +$208,122,003 $11.94 136
2023 Q1 61,209,087 $818,137,120 -$10,189,943 $13.37 122
2022 Q4 59,797,551 $1,286,831,022 -$37,719,296 $21.52 105
2022 Q3 60,343,678 $1,208,648,617 +$24,007,409 $20.03 87
2022 Q2 59,307,013 $1,061,573,186 +$302,547,160 $17.9 80
2022 Q1 43,302,427 $429,553,897 +$13,144,675 $9.92 66
2021 Q4 41,477,196 $698,277,000 +$74,959,681 $16.85 57
2021 Q3 19,043,827 $450,147,328 +$32,649,130 $23.73 43
2021 Q2 17,724,839 $401,085,000 +$401,084,962 $22.77 32